Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT03937635
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
NCT04776395
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT02726750
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT05136807
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT05312255
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT03631043
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02492750
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Active, Not Recruiting
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
NCT02603887
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
NCT05014646
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Atrium Health University City/LCI-University Charlotte, North Carolina, United States
Active, Not Recruiting
Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)
NCT02960555
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Mount Sinai Hospital New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
NCT04370483
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States